Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Pharmacia granted rights to foam delivery technology for use with Rogaine

Jan. 4, 2002

GSK discontinues development of ADL-2-1294

Dec. 27, 2001

SkyePharma withdraws Solaraze termination notice

Dec. 27, 2001

Tetracyclic CXCR1/CXCR2 receptor antagonists in development at Pfizer

Dec. 18, 2001

U.S. clearance for Elidel Cream 1% for mild to moderate eczema

Dec. 18, 2001

Enrollment ahead of schedule in ISAtx-247 phase II psoriasis trial

Dec. 17, 2001

SkyePharma and Astralis sign agreements for Psoraxine

Dec. 14, 2001

CXCR1/CXCR2 receptor antagonists in the GSK pipeline

Dec. 13, 2001

Preparation and use of CXCR2 receptor modulators disclosed by AstraZeneca

Dec. 12, 2001

Biora licenses rights to wound healing product to Molnlycke Health Care

Dec. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...